Estimation of skeletal muscle energy metabolism in Machado-Joseph disease using 31P-MR spectroscopy

Movement Disorders

Volumn 26, Issue 1, 2011, Pages 165-168

  Yabe, Ichiro ^a   Tha, Khin K ^a   Yokota, Takashi ^a   Sato, Kazunori ^a   Soma, Hiroyuki ^a   Takei, Asako ^b   Terae, Satoshi ^a   Okita, Koichi ^c   Sasaki, Hidenao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Hokuyukai Neurology Hospital   (Japan)

^c HOKUSHO UNIVERSITY   (Japan)

Author keywords

31P MRS; Cerebellar ataxia; Machado Joseph disease; Muscle energy metabolism; SARA; Surrogate marker

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ADULT; AGED; ARTICLE; ATAXIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENERGY METABOLISM; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; MACHADO JOSEPH DISEASE; MALE; MITOCHONDRION; NON INVASIVE PROCEDURE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RANGE OF MOTION; SKELETAL MUSCLE; SUPINE POSITION;

ADULT; AGED; ENERGY METABOLISM; FEMALE; HUMANS; MACHADO-JOSEPH DISEASE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHORUS ISOTOPES;

EID: 79951480711     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23335     Document Type: Article

References (13)

1. Lodi R, Schapira AH, Manners D, et al. Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy. Ann Neurol 2000; 48: 72-76.
2. Lodi R, Hart PE, Rajagopalan B, et al. Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia. Ann Neurol 2001; 49: 590-596.
3. Basri R, Yabe I, Soma H, Sasaki H. Spectrum and prevalence of autosomal dominant spinocerebellar ataxia in Hokkaido, the northern island of Japan: a study of 113 Japanese families. J Hum Genet 2007; 52: 848-855.
4. Nozaki H, Ikeuchi T, Kawakami A, et al. Clinical and genetic characterizations of 16q-linked autosomal dominant spinocerebellar ataxia (AD-SCA) and frequency analysis of AD-SCA in the Japanese population. Mov Disord 2007; 22: 857-862.
5. Takano H, Cancel G, Ikeuchi T, et al. Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. Am J Hum Genet 1998; 63: 1060-1066.
6. Katsuno M, Adachi H, Doyu M, et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 2003; 9: 768-773.
7. Imarisio S, Carmichael J, Korolchuk V, et al. Huntington's disease: from pathology and genetics to potential therapies. Biochem J 2008; 412: 191-209.
8. Katsuno M, Banno H, Suzuki K, et al. Molecular genetics and biomarkers of polyglutamine diseases. Curr Mol Med 2008; 8: 221-234.
9. Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006; 66: 1717-1720.
10. McCully K, Mancini D, Levine S. Nuclear magnetic resonance spectroscopy: its role in providing valuable insight into diverse clinical problems. Chest 1999; 116: 1434-1441.
11. Pathare N, Vandenborne K, Liu M, Stevens JE, Li Y, Frimel TN, Walter GA. Alterations in inorganic phosphate in mouse hindlimb muscles during limb disuse. NMR Biomed 2008; 21: 101-110.
12. França MCJr, D'Abreu A, Nucci A, Lopes-Cendes I. Muscle excitability abnormalities in Machado-Joseph disease. Arch Neurol 2008; 65: 525-529.
13. Kanai K, Kuwabara S, Arai K, Sung JY, Ogawara K, Hattori T. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 2003; 126: 965-973.